Astrazeneca sells historic R&D home
ALDERLEY PARK, CHESHIRE – Astrazeneca plc has sold its historic research and development home at Alderley Park, Cheshire, for development as a bioincubator and science park, as it advances the plan to bring small molecules and biologics R&D carried out by the Medimmune Inc. subsidiary together at a new $500 million global research center it is building in Cambridge.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST